USE CASES
01
Actively monitor portfolio companies’ healthcare spend year-round.
Your advisors shouldn’t be the only ones that understand your portfolio healthcare spend. So should you. Claren replaces reactive decisions at annual review time with active, year-round oversight, so you’re already prepared with actual spend data at renewal time. Monitor claim trends, track benefit utilization, and ensure vendors adhere to performance guarantees – across every portfolio company.
02
Confidently demystify renewal negotiations.
Healthcare and pharmacy data complexity – and information asymmetry – often lead to vendor pricing misalignment. Claren levels the playing field, with in-house renewal readiness: equipping you with granular, verifiable spend analytics. So you’re more informed during renewal negotiations.
03
Mitigate health spend risk at due diligence.
Know what you’re buying, before you own it. Proactively audit your target company’s hidden healthcare costs, overspending, compliance risks, and plan inefficiencies during due diligence. So you can find a clear, actionable path to post-close value creation – and negotiate transaction terms accordingly.